NCT07206264 2025-10-03ADAPT-MCLTianjin Medical University Cancer Institute and HospitalPhase 2 Not yet recruiting45 enrolled
NCT06015464 2023-08-29An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityUnknown81 enrolled